Comparison of anthracyclines used for induction chemotherapy in patients with FLT3 -ITD-mutated acute myeloid leukemia-Reference-Cited by-同舟云学术

Comparison of anthracyclines used for induction chemotherapy in patients with FLT3 -ITD-mutated acute myeloid leukemia

Published:2018-05 Issue: Volume:68 Page:51-56
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Choi Eun-Ji^ORCID,Lee Je-Hwan^ORCID,Lee Jung-Hee,Park Han-Seung,Ko Sun-Hye,Hur Eun-Hye,Moon Juhyun,Goo Bon-Kwan,Kim Yeonhee,Seol Miee,Lee Young-Shin,Kang Young-Ah,Jeon Mijin,Woo Ji Min,Lee Kyoo-Hyung

Funder

National Research Foundation of Korea

Asan Institute for Life Sciences, Seoul, Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference22 articles.

1. FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?;Levis;Hematol. Am. Soc. Hematol. Educ. Progr.,2013

2. Flt3 inhibitors: recent advances and problems for clinical application;Kiyoi;Nagoya J. Med. Sci.,2015

3. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N. Engl. J. Med.,2009

4. A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia;Lee;Blood,2011

5. Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups;Luskin;Blood,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment outcomes from a retrospective cohort of patients with acute myeloid leukemia from an urban safety net hospital;Journal of Oncology Pharmacy Practice;2024-02-06

2. Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia;Haematologica;2023-06-22

3. Evaluating the clinical significance of FLT3 mutation status in Syrian newly diagnosed acute myeloid leukemia patients with normal karyotype;Heliyon;2022-11

4. Autophagy in Hematological Malignancies;Cancers;2022-10-17

5. Triple targeted therapy is a new perspective treatment strategy for patients with FLT3-mutated acute myeloid leukemia. the literature review and single-centre experience;Russian Journal for Personalized Medicine;2022-09-16